Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia

Overexpression of the mammalian homolog of the unc-18 gene (munc18-1) has been described in the brain of subjects with schizophrenia. Munc18-1 protein is involved in membrane fusion processes, exocytosis and neurotransmitter release. A transgenic mouse strain that overexpresses the protein isoform m...

Full description

Saved in:
Bibliographic Details
Published inTranslational psychiatry Vol. 3; no. 1; p. e221
Main Authors Urigüen, L, Gil-Pisa, I, Munarriz-Cuezva, E, Berrocoso, E, Pascau, J, Soto-Montenegro, M L, Gutiérrez-Adán, A, Pintado, B, Madrigal, J L M, Castro, E, Sánchez-Blázquez, P, Ortega, J E, Guerrero, M J, Ferrer-Alcon, M, García-Sevilla, J A, Micó, J A, Desco, M, Leza, J C, Pazos, Á, Garzón, J, Meana, J J
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.01.2013
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Overexpression of the mammalian homolog of the unc-18 gene (munc18-1) has been described in the brain of subjects with schizophrenia. Munc18-1 protein is involved in membrane fusion processes, exocytosis and neurotransmitter release. A transgenic mouse strain that overexpresses the protein isoform munc18-1a in the brain was characterized. This animal displays several schizophrenia-related behaviors, supersensitivity to hallucinogenic drugs and deficits in prepulse inhibition that reverse after antipsychotic treatment. Relevant brain areas (that is, cortex and striatum) exhibit reduced expression of dopamine D 1 receptors and dopamine transporters together with enhanced amphetamine-induced in vivo dopamine release. Magnetic resonance imaging demonstrates decreased gray matter volume in the transgenic animal. In conclusion, the mouse overexpressing brain munc18-1a represents a new valid animal model that resembles functional and structural abnormalities in patients with schizophrenia. The animal could provide valuable insights into phenotypic aspects of this psychiatric disorder.
AbstractList Overexpression of the mammalian homolog of the unc-18 gene (munc18-1) has been described in the brain of subjects with schizophrenia. Munc18-1 protein is involved in membrane fusion processes, exocytosis and neurotransmitter release. A transgenic mouse strain that overexpresses the protein isoform munc18-1a in the brain was characterized. This animal displays several schizophrenia-related behaviors, supersensitivity to hallucinogenic drugs and deficits in prepulse inhibition that reverse after antipsychotic treatment. Relevant brain areas (that is, cortex and striatum) exhibit reduced expression of dopamine D 1 receptors and dopamine transporters together with enhanced amphetamine-induced in vivo dopamine release. Magnetic resonance imaging demonstrates decreased gray matter volume in the transgenic animal. In conclusion, the mouse overexpressing brain munc18-1a represents a new valid animal model that resembles functional and structural abnormalities in patients with schizophrenia. The animal could provide valuable insights into phenotypic aspects of this psychiatric disorder.
Overexpression of the mammalian homolog of the unc-18 gene (munc18-1) has been described in the brain of subjects with schizophrenia. Munc18-1 protein is involved in membrane fusion processes, exocytosis and neurotransmitter release. A transgenic mouse strain that overexpresses the protein isoform munc18-1a in the brain was characterized. This animal displays several schizophrenia-related behaviors, supersensitivity to hallucinogenic drugs and deficits in prepulse inhibition that reverse after antipsychotic treatment. Relevant brain areas (that is, cortex and striatum) exhibit reduced expression of dopamine D(1) receptors and dopamine transporters together with enhanced amphetamine-induced in vivo dopamine release. Magnetic resonance imaging demonstrates decreased gray matter volume in the transgenic animal. In conclusion, the mouse overexpressing brain munc18-1a represents a new valid animal model that resembles functional and structural abnormalities in patients with schizophrenia. The animal could provide valuable insights into phenotypic aspects of this psychiatric disorder.Overexpression of the mammalian homolog of the unc-18 gene (munc18-1) has been described in the brain of subjects with schizophrenia. Munc18-1 protein is involved in membrane fusion processes, exocytosis and neurotransmitter release. A transgenic mouse strain that overexpresses the protein isoform munc18-1a in the brain was characterized. This animal displays several schizophrenia-related behaviors, supersensitivity to hallucinogenic drugs and deficits in prepulse inhibition that reverse after antipsychotic treatment. Relevant brain areas (that is, cortex and striatum) exhibit reduced expression of dopamine D(1) receptors and dopamine transporters together with enhanced amphetamine-induced in vivo dopamine release. Magnetic resonance imaging demonstrates decreased gray matter volume in the transgenic animal. In conclusion, the mouse overexpressing brain munc18-1a represents a new valid animal model that resembles functional and structural abnormalities in patients with schizophrenia. The animal could provide valuable insights into phenotypic aspects of this psychiatric disorder.
Overexpression of the mammalian homolog of the unc-18 gene (munc18-1) has been described in the brain of subjects with schizophrenia. Munc18-1 protein is involved in membrane fusion processes, exocytosis and neurotransmitter release. A transgenic mouse strain that overexpresses the protein isoform munc18-1a in the brain was characterized. This animal displays several schizophrenia-related behaviors, supersensitivity to hallucinogenic drugs and deficits in prepulse inhibition that reverse after antipsychotic treatment. Relevant brain areas (that is, cortex and striatum) exhibit reduced expression of dopamine D(1) receptors and dopamine transporters together with enhanced amphetamine-induced in vivo dopamine release. Magnetic resonance imaging demonstrates decreased gray matter volume in the transgenic animal. In conclusion, the mouse overexpressing brain munc18-1a represents a new valid animal model that resembles functional and structural abnormalities in patients with schizophrenia. The animal could provide valuable insights into phenotypic aspects of this psychiatric disorder.
Author García-Sevilla, J A
Castro, E
Munarriz-Cuezva, E
Ortega, J E
Gil-Pisa, I
Guerrero, M J
Berrocoso, E
Garzón, J
Madrigal, J L M
Urigüen, L
Gutiérrez-Adán, A
Pintado, B
Sánchez-Blázquez, P
Desco, M
Micó, J A
Ferrer-Alcon, M
Leza, J C
Pazos, Á
Pascau, J
Meana, J J
Soto-Montenegro, M L
Author_xml – sequence: 1
  givenname: L
  surname: Urigüen
  fullname: Urigüen, L
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Pharmacology, University of the Basque Country UPV/EHU Leioa, BioCruces Health Research Institute
– sequence: 2
  givenname: I
  surname: Gil-Pisa
  fullname: Gil-Pisa, I
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Pharmacology, University of the Basque Country UPV/EHU Leioa
– sequence: 3
  givenname: E
  surname: Munarriz-Cuezva
  fullname: Munarriz-Cuezva, E
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Pharmacology, University of the Basque Country UPV/EHU Leioa
– sequence: 4
  givenname: E
  surname: Berrocoso
  fullname: Berrocoso, E
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Neuroscience, University of Cádiz
– sequence: 5
  givenname: J
  surname: Pascau
  fullname: Pascau, J
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Experimental Medicine and Surgery, General Hospital Gregorio Marañón
– sequence: 6
  givenname: M L
  surname: Soto-Montenegro
  fullname: Soto-Montenegro, M L
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Experimental Medicine and Surgery, General Hospital Gregorio Marañón
– sequence: 7
  givenname: A
  surname: Gutiérrez-Adán
  fullname: Gutiérrez-Adán, A
  organization: Department of Animal Reproduction, INIA
– sequence: 8
  givenname: B
  surname: Pintado
  fullname: Pintado, B
  organization: Department of Animal Reproduction, INIA
– sequence: 9
  givenname: J L M
  surname: Madrigal
  fullname: Madrigal, J L M
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Pharmacology, Faculty of Medicine, Complutense University
– sequence: 10
  givenname: E
  surname: Castro
  fullname: Castro, E
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Physiology and Pharmacology, University of Cantabria, Institute of Biomedicine and Biotechnology of Cantabria IBBTEC)
– sequence: 11
  givenname: P
  surname: Sánchez-Blázquez
  fullname: Sánchez-Blázquez, P
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Cajal Institute, CSIC
– sequence: 12
  givenname: J E
  surname: Ortega
  fullname: Ortega, J E
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Pharmacology, University of the Basque Country UPV/EHU Leioa, BioCruces Health Research Institute
– sequence: 13
  givenname: M J
  surname: Guerrero
  fullname: Guerrero, M J
  organization: Brainco Biopharma, SL, Derio
– sequence: 14
  givenname: M
  surname: Ferrer-Alcon
  fullname: Ferrer-Alcon, M
  organization: Brainco Biopharma, SL, Derio
– sequence: 15
  givenname: J A
  surname: García-Sevilla
  fullname: García-Sevilla, J A
  organization: Neuropharmacology Laboratory, IUNICS, University of Balearic Islands, Palma de Mallorca and Redes Temáticas de Investigación Cooperativa en Salud, Red de Trastornos Adictivos (RETICS-RTA)
– sequence: 16
  givenname: J A
  surname: Micó
  fullname: Micó, J A
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Neuroscience, University of Cádiz
– sequence: 17
  givenname: M
  surname: Desco
  fullname: Desco, M
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Experimental Medicine and Surgery, General Hospital Gregorio Marañón, Department of Bioengineering and Aerospace Engineering, Carlos III University
– sequence: 18
  givenname: J C
  surname: Leza
  fullname: Leza, J C
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Pharmacology, Faculty of Medicine, Complutense University
– sequence: 19
  givenname: Á
  surname: Pazos
  fullname: Pazos, Á
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Physiology and Pharmacology, University of Cantabria, Institute of Biomedicine and Biotechnology of Cantabria IBBTEC)
– sequence: 20
  givenname: J
  surname: Garzón
  fullname: Garzón, J
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Cajal Institute, CSIC
– sequence: 21
  givenname: J J
  surname: Meana
  fullname: Meana, J J
  email: javier.meana@ehu.es
  organization: Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, Department of Pharmacology, University of the Basque Country UPV/EHU Leioa, BioCruces Health Research Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23340504$$D View this record in MEDLINE/PubMed
BookMark eNptkktrFTEUx4NUbK1duZeAG8HONY95ZLoQavEFBTfdhzOZc--kzCRjkrlYv0K_tKm3lWtpNgknv_Pnfx4vyYHzDgl5zdmKM6k-pHklGBcrXrbPyJHglSokV-pg731ITmK8ZvlUpeINf0EOhZQlq1h5RG4_4QBb6wOMp9ThErwZcLIGRgqup5MP8-BHv_kbMQO4DUZqXb8Y7Gl3Q9OA1G8x4K85YIzWO-rXdFqc4argkFHaBbC7qDV4RgOOuAVnkCZPoxnsbz8PAZ2FV-T5GsaIJ_f3Mbn68vnq4ltx-ePr94vzy8JUXKRCdqURoHgFsun6Zi0ZcKiwanpgDDowxvCy7luhyg5KgR1T0KAS2CKyGuQx-biTnZduwt6gS7l6PQc7QbjRHqz-_8fZQW_8VsuqrhuhssC7e4Hgfy4Yk55sNDiO4NAvUXPRSMXq3O2Mvn2EXvsluFyd5k3LpWpbJTL1Zt_RPysPY8oA3wEm-BgDrrWxCVLudjZoR82ZvtsGnWZ9tw06b0POef8o50H2afp0R8dM5SGHPaNP4H8AfGHG1w
CitedBy_id crossref_primary_10_1016_j_neuroscience_2014_07_027
crossref_primary_10_1016_j_neuroscience_2018_12_015
crossref_primary_10_1186_s13024_015_0061_4
crossref_primary_10_1002_humu_22475
crossref_primary_10_1093_hmg_ddx379
crossref_primary_10_1007_s12035_016_0029_6
crossref_primary_10_1016_j_pnpbp_2020_110030
crossref_primary_10_1016_j_euroneuro_2016_11_016
crossref_primary_10_1083_jcb_201308026
crossref_primary_10_1177_26330040241257221
crossref_primary_10_1002_dneu_22892
crossref_primary_10_1016_j_biopsych_2015_07_013
crossref_primary_10_1016_j_euroneuro_2021_02_001
crossref_primary_10_1080_19336896_2021_1883980
crossref_primary_10_1016_j_neubiorev_2020_06_010
crossref_primary_10_1016_j_rpsm_2018_10_001
crossref_primary_10_1016_j_rpsmen_2018_10_001
crossref_primary_10_1007_s11920_016_0710_5
crossref_primary_10_1016_j_pnpbp_2017_12_001
crossref_primary_10_1016_j_biopsych_2014_12_012
crossref_primary_10_1038_s41598_017_04132_7
Cites_doi 10.1016/S0140-6736(09)60995-8
10.1016/S0166-4328(03)00187-6
10.1023/A:1008926022370
10.1016/j.neuropharm.2004.01.003
10.1126/science.1161748
10.1016/j.neuron.2006.09.023
10.1001/archgenpsychiatry.2011.150
10.1093/schbul/sbn135
10.1016/S0920-9964(00)00095-5
10.1038/385634a0
10.1038/nn.2647
10.1007/s00213-004-1793-y
10.1038/mp.2008.7
10.1017/S1461145711000861
10.1176/appi.ajp.159.5.761
10.1016/S0074-7742(06)78001-1
10.1007/s002130100810
10.1016/S0028-3908(00)00094-0
10.1016/j.biopsych.2006.05.008
10.1523/JNEUROSCI.22-09-03708.2002
10.1192/S0007125000293598
10.1111/j.1471-4159.1993.tb07468.x
10.1176/appi.ajp.162.12.2233
10.1093/schbul/sbp006
10.1007/s00213-009-1608-2
10.1007/s002130000532
10.1016/S0896-6273(00)80086-0
10.1038/379606a0
10.1093/cercor/8.2.108
10.1016/j.euroneuro.2010.04.008
10.1093/schbul/sbp125
10.1016/j.euroneuro.2010.07.008
10.1016/j.schres.2005.05.019
10.1016/j.tins.2007.08.008
10.1083/jcb.129.1.105
10.1038/nrn898
10.1111/j.1749-6632.2008.03987.x
10.1006/geno.1997.5202
10.1038/nature06612
10.1001/archgenpsychiatry.2012.169
10.1016/j.schres.2005.08.014
10.1016/j.nbd.2008.09.016
10.1016/j.biopsych.2009.07.029
10.1073/pnas.93.17.9235
10.1517/14728222.10.4.515
10.1097/FBP.0b013e32830dc110
10.1016/j.lfs.2010.03.018
10.1016/j.neuron.2007.01.008
10.1176/ajp.156.9.1358
10.18388/abp.2008_3022
ContentType Journal Article
Copyright The Author(s) 2013
Copyright Nature Publishing Group Jan 2013
Copyright © 2013 Macmillan Publishers Limited 2013 Macmillan Publishers Limited
Copyright_xml – notice: The Author(s) 2013
– notice: Copyright Nature Publishing Group Jan 2013
– notice: Copyright © 2013 Macmillan Publishers Limited 2013 Macmillan Publishers Limited
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/tp.2012.149
DatabaseName SpringerOpen Free (Free internet resource, activated by CARLI)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Munc18-1a and schizophrenic-like phenotype
EISSN 2158-3188
EndPage e221
ExternalDocumentID PMC3566728
4068209921
23340504
10_1038_tp_2012_149
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
3V.
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAJSJ
AAKDD
ABUWG
ACGFO
ACGFS
ACMJI
ACSMW
ADBBV
ADFRT
AENEX
AFKRA
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EJD
EMOBN
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
KQ8
LGEZI
LOTEE
M1P
M~E
NADUK
NAO
NXXTH
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AARCD
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c512t-3b4c2a815a37bd7f30a1a5e57da00abaccc146d9284ba42eb08a7e82e9ee06a3
IEDL.DBID 7X7
ISSN 2158-3188
IngestDate Thu Aug 21 17:57:59 EDT 2025
Fri Jul 11 10:27:09 EDT 2025
Wed Aug 13 07:17:26 EDT 2025
Thu Jan 02 22:14:07 EST 2025
Tue Jul 01 00:54:59 EDT 2025
Thu Apr 24 23:12:27 EDT 2025
Fri Feb 21 02:39:00 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords PPI
Munc18-1a
schizophrenia
SNARE
Language English
License This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c512t-3b4c2a815a37bd7f30a1a5e57da00abaccc146d9284ba42eb08a7e82e9ee06a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/1791389982?pq-origsite=%requestingapplication%
PMID 23340504
PQID 1791389982
PQPubID 2041978
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3566728
proquest_miscellaneous_1273806548
proquest_journals_1791389982
pubmed_primary_23340504
crossref_citationtrail_10_1038_tp_2012_149
crossref_primary_10_1038_tp_2012_149
springer_journals_10_1038_tp_2012_149
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-01-01
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – month: 01
  year: 2013
  text: 2013-01-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: United States
PublicationTitle Translational psychiatry
PublicationTitleAbbrev Transl Psychiatry
PublicationTitleAlternate Transl Psychiatry
PublicationYear 2013
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Vaidya, Castro, Pei, Sprakes, Grahame-Smith (CR18) 2001; 40
Kosaka, Takahashi, Ito, Takano, Fujimura, Matsumoto (CR41) 2010; 86
Burgoyne, Barclay, Ciufo, Graham, Handley, Morgan (CR7) 2009; 1152
Uriguen, Perez-Rial, Ledent, Palomo, Manzanares (CR21) 2004; 46
Behan, Byrne, Dunn, Cagney, Cotter (CR10) 2009; 14
Sudhof, Rothman (CR6) 2009; 323
Tamminga (CR37) 1999; 37
Ortega, Fernandez-Pastor, Callado, Meana (CR23) 2010; 20
Honea, Crow, Passingham, Mackay (CR3) 2005; 162
O'Tuathaigh, Kirby, Moran, Waddington (CR29) 2010; 36
Laruelle, Abi-Dargham, van Dyck, Gil, D'Souza, Erdos (CR36) 1996; 93
Paxinos, Franklin (CR22) 2001
van Os, Kapur (CR1) 2009; 374
Swanson, Steel, Valle (CR13) 1998; 48
Vrana, Vrana, Koves, Smith, Dworkin (CR50) 1993; 61
Aleman, Hijman, de Haan, Kahn (CR31) 1999; 156
Garcia, McPherson, Chilcote, Takei, De Camilli (CR12) 1995; 129
Sawiak, Wood, Williams, Morton, Carpenter (CR24) 2009; 33
Laakso, Bergman, Haaparanta, Vilkman, Solin, Syvalahti (CR35) 2001; 52
Guillin, Abi-Dargham, Laruelle (CR45) 2007; 78
Rodriguiz, Chu, Caron, Wetsel (CR48) 2004; vol. 148
Okubo, Suhara, Suzuki, Kobayashi, Inoue, Terasaki (CR34) 1997; 385
Johnson, Oliver, Davies (CR5) 2008; 55
Rizo, Sudhof (CR27) 2002; 3
Karlsson, Farde, Halldin, Sedvall (CR42) 2002; 159
Conti, DeBiasi, Minelli, Rothstein, Melone (CR25) 1998; 8
Arango, Rapado-Castro, Reig, Castro-Fornieles, Gonzalez-Pinto, Otero (CR4) 2012; 69
Garcia-Sevilla, Alvaro-Bartolome, Diez-Alarcia, Ramos-Miguel, Puigdemont, Perez (CR17) 2010; 20
Howes, Kambeitz, Kim, Stahl, Slifstein, Abi-Dargham (CR51) 2012; 69
Arguello, Gogos (CR28) 2006; 52
Giros, Jaber, Jones, Wightman, Caron (CR47) 1996; 379
Gutierrez-Adan, Pintado (CR16) 2000; 9
Howes, Kapur (CR2) 2009; 35
Rothstein, Dykes-Hoberg, Pardo, Bristol, Jin, Kuncl (CR26) 1996; 16
Powell, Young, Ong, Caron, Geyer (CR49) 2008; 19
Toonen, Verhage (CR8) 2007; 30
Goldman-Rakic, Castner, Svensson, Siever, Williams (CR33) 2004; 174
Abi-Dargham, Mawlawi, Lombardo, Gil, Martinez, Huang (CR43) 2002; 22
Gonzalez-Maeso, Weisstaub, Zhou, Chan, Ivic, Ang (CR30) 2007; 53
Nestler, Hyman (CR14) 2010; 13
Glantz, Gilmore, Lieberman, Jarskog (CR38) 2006; 81
Seeman (CR44) 2006; 10
Powell, Miyakawa (CR15) 2006; 59
Bernstein, Bogerts, Keilhoff (CR39) 2005; 78
Gil-Pisa, Munarriz-Cuezva, Ramos-Miguel, Uriguen, Meana, Garcia-Sevilla (CR11) 2012; 14
Braff, Geyer, Swerdlow (CR32) 2001; 156
Castillo, Ghose, Tamminga, Ulery-Reynolds (CR9) 2010; 67
Urigüen, Garcia-Fuster, Callado, Morentin, La Harpe, Casado (CR19) 2009; 206
Silvestri, Seeman, Negrete, Houle, Shammi, Remington (CR46) 2000; 152
Gonzalez-Maeso, Ang, Yuen, Chan, Weisstaub, Lopez-Gimenez (CR20) 2008; 452
Buckley, Miller, Lehrer, Castle (CR40) 2009; 35
P Karlsson (BFtp2012149_CR42) 2002; 159
TC Sudhof (BFtp2012149_CR6) 2009; 323
J Gonzalez-Maeso (BFtp2012149_CR20) 2008; 452
SB Powell (BFtp2012149_CR49) 2008; 19
L Uriguen (BFtp2012149_CR21) 2004; 46
JA Garcia-Sevilla (BFtp2012149_CR17) 2010; 20
RM Rodriguiz (BFtp2012149_CR48) 2004; vol. 148
C Arango (BFtp2012149_CR4) 2012; 69
J Rizo (BFtp2012149_CR27) 2002; 3
DA Swanson (BFtp2012149_CR13) 1998; 48
C Tamminga (BFtp2012149_CR37) 1999; 37
A Laakso (BFtp2012149_CR35) 2001; 52
P Seeman (BFtp2012149_CR44) 2006; 10
S Silvestri (BFtp2012149_CR46) 2000; 152
OD Howes (BFtp2012149_CR2) 2009; 35
RD Johnson (BFtp2012149_CR5) 2008; 55
SJ Sawiak (BFtp2012149_CR24) 2009; 33
EP Garcia (BFtp2012149_CR12) 1995; 129
MA Castillo (BFtp2012149_CR9) 2010; 67
J Gonzalez-Maeso (BFtp2012149_CR30) 2007; 53
RD Burgoyne (BFtp2012149_CR7) 2009; 1152
AT Behan (BFtp2012149_CR10) 2009; 14
CM Powell (BFtp2012149_CR15) 2006; 59
J Kosaka (BFtp2012149_CR41) 2010; 86
PS Goldman-Rakic (BFtp2012149_CR33) 2004; 174
M Laruelle (BFtp2012149_CR36) 1996; 93
J van Os (BFtp2012149_CR1) 2009; 374
PA Arguello (BFtp2012149_CR28) 2006; 52
B Giros (BFtp2012149_CR47) 1996; 379
G Paxinos (BFtp2012149_CR22) 2001
VA Vaidya (BFtp2012149_CR18) 2001; 40
Y Okubo (BFtp2012149_CR34) 1997; 385
A Gutierrez-Adan (BFtp2012149_CR16) 2000; 9
LA Glantz (BFtp2012149_CR38) 2006; 81
OD Howes (BFtp2012149_CR51) 2012; 69
RF Toonen (BFtp2012149_CR8) 2007; 30
I Gil-Pisa (BFtp2012149_CR11) 2012; 14
A Aleman (BFtp2012149_CR31) 1999; 156
L Urigüen (BFtp2012149_CR19) 2009; 206
PF Buckley (BFtp2012149_CR40) 2009; 35
JE Ortega (BFtp2012149_CR23) 2010; 20
DL Braff (BFtp2012149_CR32) 2001; 156
EJ Nestler (BFtp2012149_CR14) 2010; 13
JD Rothstein (BFtp2012149_CR26) 1996; 16
SL Vrana (BFtp2012149_CR50) 1993; 61
A Abi-Dargham (BFtp2012149_CR43) 2002; 22
CM O'Tuathaigh (BFtp2012149_CR29) 2010; 36
HG Bernstein (BFtp2012149_CR39) 2005; 78
O Guillin (BFtp2012149_CR45) 2007; 78
F Conti (BFtp2012149_CR25) 1998; 8
R Honea (BFtp2012149_CR3) 2005; 162
12154365 - Nat Rev Neurosci. 2002 Aug;3(8):641-53
18985177 - Acta Biochim Pol. 2008;55(4):619-28
18297054 - Nature. 2008 Mar 6;452(7183):93-7
8785064 - Neuron. 1996 Mar;16(3):675-86
9545644 - Genomics. 1998 Mar 15;48(3):373-6
8628395 - Nature. 1996 Feb 15;379(6566):606-12
16330585 - Am J Psychiatry. 2005 Dec;162(12):2233-45
8799184 - Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9235-40
19011234 - Schizophr Bull. 2009 Mar;35(2):383-402
19748077 - Biol Psychiatry. 2010 Feb 1;67(3):208-16
16848689 - Expert Opin Ther Targets. 2006 Aug;10(4):515-31
9542890 - Cereb Cortex. 1998 Mar;8(2):108-16
20877280 - Nat Neurosci. 2010 Oct;13(10):1161-9
17349856 - Int Rev Neurobiol. 2007;78:1-39
19934211 - Schizophr Bull. 2010 Mar;36(2):271-88
16797265 - Biol Psychiatry. 2006 Jun 15;59(12):1198-207
19161378 - Ann N Y Acad Sci. 2009 Jan;1152:76-86
11549226 - Psychopharmacology (Berl). 2001 Jul;156(2-3):234-58
19325164 - Schizophr Bull. 2009 May;35(3):549-62
21669024 - Int J Neuropsychopharmacol. 2012 Jun;15(5):573-88
10484945 - Am J Psychiatry. 1999 Sep;156(9):1358-66
18930824 - Neurobiol Dis. 2009 Jan;33(1):20-7
7902421 - J Neurochem. 1993 Dec;61(6):2262-8
11077070 - Neuropharmacology. 2001;40(1):48-56
19700006 - Lancet. 2009 Aug 22;374(9690):635-45
17270739 - Neuron. 2007 Feb 1;53(3):439-52
19652957 - Psychopharmacology (Berl). 2009 Oct;206(2):313-24
16226876 - Schizophr Res. 2006 Jan 1;81(1):47-63
22474070 - Arch Gen Psychiatry. 2012 Aug;69(8):776-86
11595398 - Schizophr Res. 2001 Oct 1;52(1-2):115-20
9024661 - Nature. 1997 Feb 13;385(6617):634-6
10951692 - Transgenic Res. 2000 Apr;9(2):81-9
16005189 - Schizophr Res. 2005 Oct 1;78(1):69-86
11986129 - Am J Psychiatry. 2002 May;159(5):761-7
18268500 - Mol Psychiatry. 2009 Jun;14(6):601-13
22213785 - Arch Gen Psychiatry. 2012 Jan;69(1):16-26
20813509 - Eur Neuropsychopharmacol. 2010 Nov;20(11):813-22
7698978 - J Cell Biol. 1995 Apr;129(1):105-20
17015235 - Neuron. 2006 Oct 5;52(1):179-96
18690110 - Behav Pharmacol. 2008 Sep;19(5-6):562-5
15081793 - Neuropharmacology. 2004 Jun;46(7):966-73
14684259 - Behav Brain Res. 2004 Jan 5;148(1-2):185-98
20361984 - Life Sci. 2010 May 22;86(21-22):814-8
20493668 - Eur Neuropsychopharmacol. 2010 Oct;20(10):721-30
11978847 - J Neurosci. 2002 May 1;22(9):3708-19
15118803 - Psychopharmacology (Berl). 2004 Jun;174(1):3-16
17956762 - Trends Neurosci. 2007 Nov;30(11):564-72
10211134 - Br J Psychiatry Suppl. 1999;(37):12-5
11057521 - Psychopharmacology (Berl). 2000 Oct;152(2):174-80
19164740 - Science. 2009 Jan 23;323(5913):474-7
References_xml – volume: 374
  start-page: 635
  year: 2009
  end-page: 645
  ident: CR1
  article-title: Schizophrenia
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)60995-8
– volume: vol. 148
  start-page: 185
  year: 2004
  end-page: 198
  ident: CR48
  article-title: Aberrant responses in social interaction of dopamine transporter knockout mice
  publication-title: Behav Brain Res
  doi: 10.1016/S0166-4328(03)00187-6
– volume: 9
  start-page: 81
  year: 2000
  end-page: 89
  ident: CR16
  article-title: Effect of flanking matrix attachment regions on the expression of microinjected transgenes during preimplantation development of mouse embryos
  publication-title: Transgenic Res
  doi: 10.1023/A:1008926022370
– volume: 46
  start-page: 966
  year: 2004
  end-page: 973
  ident: CR21
  article-title: Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2004.01.003
– volume: 156
  start-page: 1358
  year: 1999
  end-page: 1366
  ident: CR31
  article-title: Memory impairment in schizophrenia: a meta-analysis
  publication-title: Am J Psychiatry
– volume: 323
  start-page: 474
  year: 2009
  end-page: 477
  ident: CR6
  article-title: Membrane fusion: grappling with SNARE and SM proteins
  publication-title: Science
  doi: 10.1126/science.1161748
– volume: 52
  start-page: 179
  year: 2006
  end-page: 196
  ident: CR28
  article-title: Modeling madness in mice: one piece at a time
  publication-title: Neuron
  doi: 10.1016/j.neuron.2006.09.023
– volume: 69
  start-page: 16
  year: 2012
  end-page: 26
  ident: CR4
  article-title: Progressive brain changes in children and adolescents with first-episode psychosis
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.150
– volume: 35
  start-page: 383
  year: 2009
  end-page: 402
  ident: CR40
  article-title: Psychiatric comorbidities and schizophrenia
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbn135
– volume: 52
  start-page: 115
  year: 2001
  end-page: 120
  ident: CR35
  article-title: Decreased striatal dopamine transporter binding in chronic schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(00)00095-5
– volume: 385
  start-page: 634
  year: 1997
  end-page: 636
  ident: CR34
  article-title: Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET
  publication-title: Nature
  doi: 10.1038/385634a0
– volume: 13
  start-page: 1161
  year: 2010
  end-page: 1169
  ident: CR14
  article-title: Animal models of neuropsychiatric disorders
  publication-title: Nat Neurosci
  doi: 10.1038/nn.2647
– volume: 174
  start-page: 3
  year: 2004
  end-page: 16
  ident: CR33
  article-title: Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/s00213-004-1793-y
– volume: 14
  start-page: 601
  year: 2009
  end-page: 613
  ident: CR10
  article-title: Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2008.7
– volume: 14
  start-page: 573
  year: 2012
  end-page: 588
  ident: CR11
  article-title: Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment
  publication-title: Int J Neuropsychopharmacol
  doi: 10.1017/S1461145711000861
– volume: 159
  start-page: 761
  year: 2002
  end-page: 767
  ident: CR42
  article-title: PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.159.5.761
– volume: 78
  start-page: 1
  year: 2007
  end-page: 39
  ident: CR45
  article-title: Neurobiology of dopamine in schizophrenia
  publication-title: Int Rev Neurobiol
  doi: 10.1016/S0074-7742(06)78001-1
– volume: 156
  start-page: 234
  year: 2001
  end-page: 258
  ident: CR32
  article-title: Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies
  publication-title: Psychopharmacology
  doi: 10.1007/s002130100810
– volume: 40
  start-page: 48
  year: 2001
  end-page: 56
  ident: CR18
  article-title: Influence of thyroid hormone on 5-HT(1A) and 5-HT(2A) receptor-mediated regulation of hippocampal BDNF mRNA expression
  publication-title: Neuropharmacology
  doi: 10.1016/S0028-3908(00)00094-0
– volume: 59
  start-page: 1198
  year: 2006
  end-page: 1207
  ident: CR15
  article-title: Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2006.05.008
– volume: 22
  start-page: 3708
  year: 2002
  end-page: 3719
  ident: CR43
  article-title: Prefrontal dopamine D1 receptors and working memory in schizophrenia
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-09-03708.2002
– volume: 37
  start-page: 12
  year: 1999
  end-page: 15
  ident: CR37
  article-title: Glutamatergic aspects of schizophrenia
  publication-title: Br J Psychiatry Suppl
  doi: 10.1192/S0007125000293598
– volume: 61
  start-page: 2262
  year: 1993
  end-page: 2268
  ident: CR50
  article-title: Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.1993.tb07468.x
– volume: 162
  start-page: 2233
  year: 2005
  end-page: 2245
  ident: CR3
  article-title: Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.162.12.2233
– volume: 55
  start-page: 619
  year: 2008
  end-page: 628
  ident: CR5
  article-title: SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses
  publication-title: Acta Biochim Pol
– volume: 35
  start-page: 549
  year: 2009
  end-page: 562
  ident: CR2
  article-title: The dopamine hypothesis of schizophrenia: version III–the final common pathway
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp006
– volume: 206
  start-page: 313
  year: 2009
  end-page: 324
  ident: CR19
  article-title: Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-009-1608-2
– volume: 152
  start-page: 174
  year: 2000
  end-page: 180
  ident: CR46
  article-title: Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study
  publication-title: Psychopharmacology
  doi: 10.1007/s002130000532
– volume: 16
  start-page: 675
  year: 1996
  end-page: 686
  ident: CR26
  article-title: Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
  publication-title: Neuron
  doi: 10.1016/S0896-6273(00)80086-0
– volume: 379
  start-page: 606
  year: 1996
  end-page: 612
  ident: CR47
  article-title: Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
  publication-title: Nature
  doi: 10.1038/379606a0
– volume: 8
  start-page: 108
  year: 1998
  end-page: 116
  ident: CR25
  article-title: EAAC1, a high-affinity glutamate tranporter, is localized to astrocytes and gabaergic neurons besides pyramidal cells in the rat cerebral cortex
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/8.2.108
– volume: 20
  start-page: 721
  year: 2010
  end-page: 730
  ident: CR17
  article-title: Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2010.04.008
– volume: 36
  start-page: 271
  year: 2010
  end-page: 288
  ident: CR29
  article-title: Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp125
– volume: 20
  start-page: 813
  year: 2010
  end-page: 822
  ident: CR23
  article-title: potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by alpha(2)-adrenoceptor antagonism
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2010.07.008
– volume: 78
  start-page: 69
  year: 2005
  end-page: 86
  ident: CR39
  article-title: The many faces of nitric oxide in schizophrenia. A review
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2005.05.019
– volume: 30
  start-page: 564
  year: 2007
  end-page: 572
  ident: CR8
  article-title: Munc18-1 in secretion: lonely Munc joins SNARE team and takes control
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2007.08.008
– volume: 129
  start-page: 105
  year: 1995
  end-page: 120
  ident: CR12
  article-title: rbSec1A and B colocalize with syntaxin 1 and SNAP-25 throughout the axon, but are not in a stable complex with syntaxin
  publication-title: J Cell Biol
  doi: 10.1083/jcb.129.1.105
– volume: 3
  start-page: 641
  year: 2002
  end-page: 653
  ident: CR27
  article-title: Snares and Munc18 in synaptic vesicle fusion
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn898
– volume: 1152
  start-page: 76
  year: 2009
  end-page: 86
  ident: CR7
  article-title: The functions of Munc18-1 in regulated exocytosis
  publication-title: Ann NY Acad Sci
  doi: 10.1111/j.1749-6632.2008.03987.x
– volume: 48
  start-page: 373
  year: 1998
  end-page: 376
  ident: CR13
  article-title: Identification and characterization of the human ortholog of rat STXBP1, a protein implicated in vesicle trafficking and neurotransmitter release
  publication-title: Genomics
  doi: 10.1006/geno.1997.5202
– year: 2001
  ident: CR22
  publication-title: The Mouse Brain in Stereotaxic Coordinates
– volume: 452
  start-page: 93
  year: 2008
  end-page: 97
  ident: CR20
  article-title: Identification of a serotonin/glutamate receptor complex implicated in psychosis
  publication-title: Nature
  doi: 10.1038/nature06612
– volume: 69
  start-page: 776
  year: 2012
  end-page: 786
  ident: CR51
  article-title: The nature of dopamine dysfunction in schizophrenia and what this means for treatment
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2012.169
– volume: 81
  start-page: 47
  year: 2006
  end-page: 63
  ident: CR38
  article-title: Apoptotic mechanisms and the synaptic pathology of schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2005.08.014
– volume: 33
  start-page: 20
  year: 2009
  end-page: 27
  ident: CR24
  article-title: Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2008.09.016
– volume: 67
  start-page: 208
  year: 2010
  end-page: 216
  ident: CR9
  article-title: Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.07.029
– volume: 93
  start-page: 9235
  year: 1996
  end-page: 9240
  ident: CR36
  article-title: Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.93.17.9235
– volume: 10
  start-page: 515
  year: 2006
  end-page: 531
  ident: CR44
  article-title: Targeting the dopamine D2 receptor in schizophrenia
  publication-title: Expert Opin Ther Targets
  doi: 10.1517/14728222.10.4.515
– volume: 19
  start-page: 562
  year: 2008
  end-page: 565
  ident: CR49
  article-title: Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice
  publication-title: Behav Pharmacol
  doi: 10.1097/FBP.0b013e32830dc110
– volume: 86
  start-page: 814
  year: 2010
  end-page: 818
  ident: CR41
  article-title: Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2010.03.018
– volume: 53
  start-page: 439
  year: 2007
  end-page: 452
  ident: CR30
  article-title: Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior
  publication-title: Neuron
  doi: 10.1016/j.neuron.2007.01.008
– volume: 40
  start-page: 48
  year: 2001
  ident: BFtp2012149_CR18
  publication-title: Neuropharmacology
  doi: 10.1016/S0028-3908(00)00094-0
– volume: 93
  start-page: 9235
  year: 1996
  ident: BFtp2012149_CR36
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.93.17.9235
– volume: 46
  start-page: 966
  year: 2004
  ident: BFtp2012149_CR21
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2004.01.003
– volume: 69
  start-page: 776
  year: 2012
  ident: BFtp2012149_CR51
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2012.169
– volume: 61
  start-page: 2262
  year: 1993
  ident: BFtp2012149_CR50
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.1993.tb07468.x
– volume: 156
  start-page: 1358
  year: 1999
  ident: BFtp2012149_CR31
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.156.9.1358
– volume: 385
  start-page: 634
  year: 1997
  ident: BFtp2012149_CR34
  publication-title: Nature
  doi: 10.1038/385634a0
– volume: 374
  start-page: 635
  year: 2009
  ident: BFtp2012149_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)60995-8
– volume: 206
  start-page: 313
  year: 2009
  ident: BFtp2012149_CR19
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-009-1608-2
– volume: 129
  start-page: 105
  year: 1995
  ident: BFtp2012149_CR12
  publication-title: J Cell Biol
  doi: 10.1083/jcb.129.1.105
– volume: 152
  start-page: 174
  year: 2000
  ident: BFtp2012149_CR46
  publication-title: Psychopharmacology
  doi: 10.1007/s002130000532
– volume-title: The Mouse Brain in Stereotaxic Coordinates
  year: 2001
  ident: BFtp2012149_CR22
– volume: 33
  start-page: 20
  year: 2009
  ident: BFtp2012149_CR24
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2008.09.016
– volume: 36
  start-page: 271
  year: 2010
  ident: BFtp2012149_CR29
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp125
– volume: 9
  start-page: 81
  year: 2000
  ident: BFtp2012149_CR16
  publication-title: Transgenic Res
  doi: 10.1023/A:1008926022370
– volume: 14
  start-page: 601
  year: 2009
  ident: BFtp2012149_CR10
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2008.7
– volume: 3
  start-page: 641
  year: 2002
  ident: BFtp2012149_CR27
  publication-title: Nat Rev Neurosci
  doi: 10.1038/nrn898
– volume: 174
  start-page: 3
  year: 2004
  ident: BFtp2012149_CR33
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/s00213-004-1793-y
– volume: 86
  start-page: 814
  year: 2010
  ident: BFtp2012149_CR41
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2010.03.018
– volume: 156
  start-page: 234
  year: 2001
  ident: BFtp2012149_CR32
  publication-title: Psychopharmacology
  doi: 10.1007/s002130100810
– volume: 59
  start-page: 1198
  year: 2006
  ident: BFtp2012149_CR15
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2006.05.008
– volume: 55
  start-page: 619
  year: 2008
  ident: BFtp2012149_CR5
  publication-title: Acta Biochim Pol
  doi: 10.18388/abp.2008_3022
– volume: 8
  start-page: 108
  year: 1998
  ident: BFtp2012149_CR25
  publication-title: Cereb Cortex
  doi: 10.1093/cercor/8.2.108
– volume: 69
  start-page: 16
  year: 2012
  ident: BFtp2012149_CR4
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2011.150
– volume: 52
  start-page: 179
  year: 2006
  ident: BFtp2012149_CR28
  publication-title: Neuron
  doi: 10.1016/j.neuron.2006.09.023
– volume: 14
  start-page: 573
  year: 2012
  ident: BFtp2012149_CR11
  publication-title: Int J Neuropsychopharmacol
  doi: 10.1017/S1461145711000861
– volume: 10
  start-page: 515
  year: 2006
  ident: BFtp2012149_CR44
  publication-title: Expert Opin Ther Targets
  doi: 10.1517/14728222.10.4.515
– volume: 379
  start-page: 606
  year: 1996
  ident: BFtp2012149_CR47
  publication-title: Nature
  doi: 10.1038/379606a0
– volume: 30
  start-page: 564
  year: 2007
  ident: BFtp2012149_CR8
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2007.08.008
– volume: 78
  start-page: 1
  year: 2007
  ident: BFtp2012149_CR45
  publication-title: Int Rev Neurobiol
  doi: 10.1016/S0074-7742(06)78001-1
– volume: 81
  start-page: 47
  year: 2006
  ident: BFtp2012149_CR38
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2005.08.014
– volume: 52
  start-page: 115
  year: 2001
  ident: BFtp2012149_CR35
  publication-title: Schizophr Res
  doi: 10.1016/S0920-9964(00)00095-5
– volume: 323
  start-page: 474
  year: 2009
  ident: BFtp2012149_CR6
  publication-title: Science
  doi: 10.1126/science.1161748
– volume: 162
  start-page: 2233
  year: 2005
  ident: BFtp2012149_CR3
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.162.12.2233
– volume: 13
  start-page: 1161
  year: 2010
  ident: BFtp2012149_CR14
  publication-title: Nat Neurosci
  doi: 10.1038/nn.2647
– volume: 67
  start-page: 208
  year: 2010
  ident: BFtp2012149_CR9
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.07.029
– volume: 78
  start-page: 69
  year: 2005
  ident: BFtp2012149_CR39
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2005.05.019
– volume: vol. 148
  start-page: 185
  year: 2004
  ident: BFtp2012149_CR48
  publication-title: Behav Brain Res
  doi: 10.1016/S0166-4328(03)00187-6
– volume: 37
  start-page: 12
  year: 1999
  ident: BFtp2012149_CR37
  publication-title: Br J Psychiatry Suppl
  doi: 10.1192/S0007125000293598
– volume: 20
  start-page: 813
  year: 2010
  ident: BFtp2012149_CR23
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2010.07.008
– volume: 452
  start-page: 93
  year: 2008
  ident: BFtp2012149_CR20
  publication-title: Nature
  doi: 10.1038/nature06612
– volume: 35
  start-page: 549
  year: 2009
  ident: BFtp2012149_CR2
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbp006
– volume: 159
  start-page: 761
  year: 2002
  ident: BFtp2012149_CR42
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.159.5.761
– volume: 16
  start-page: 675
  year: 1996
  ident: BFtp2012149_CR26
  publication-title: Neuron
  doi: 10.1016/S0896-6273(00)80086-0
– volume: 20
  start-page: 721
  year: 2010
  ident: BFtp2012149_CR17
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2010.04.008
– volume: 19
  start-page: 562
  year: 2008
  ident: BFtp2012149_CR49
  publication-title: Behav Pharmacol
  doi: 10.1097/FBP.0b013e32830dc110
– volume: 35
  start-page: 383
  year: 2009
  ident: BFtp2012149_CR40
  publication-title: Schizophr Bull
  doi: 10.1093/schbul/sbn135
– volume: 48
  start-page: 373
  year: 1998
  ident: BFtp2012149_CR13
  publication-title: Genomics
  doi: 10.1006/geno.1997.5202
– volume: 53
  start-page: 439
  year: 2007
  ident: BFtp2012149_CR30
  publication-title: Neuron
  doi: 10.1016/j.neuron.2007.01.008
– volume: 22
  start-page: 3708
  year: 2002
  ident: BFtp2012149_CR43
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.22-09-03708.2002
– volume: 1152
  start-page: 76
  year: 2009
  ident: BFtp2012149_CR7
  publication-title: Ann NY Acad Sci
  doi: 10.1111/j.1749-6632.2008.03987.x
– reference: 17956762 - Trends Neurosci. 2007 Nov;30(11):564-72
– reference: 18297054 - Nature. 2008 Mar 6;452(7183):93-7
– reference: 20813509 - Eur Neuropsychopharmacol. 2010 Nov;20(11):813-22
– reference: 19934211 - Schizophr Bull. 2010 Mar;36(2):271-88
– reference: 19164740 - Science. 2009 Jan 23;323(5913):474-7
– reference: 18930824 - Neurobiol Dis. 2009 Jan;33(1):20-7
– reference: 15081793 - Neuropharmacology. 2004 Jun;46(7):966-73
– reference: 19652957 - Psychopharmacology (Berl). 2009 Oct;206(2):313-24
– reference: 10484945 - Am J Psychiatry. 1999 Sep;156(9):1358-66
– reference: 19161378 - Ann N Y Acad Sci. 2009 Jan;1152:76-86
– reference: 19325164 - Schizophr Bull. 2009 May;35(3):549-62
– reference: 7698978 - J Cell Biol. 1995 Apr;129(1):105-20
– reference: 7902421 - J Neurochem. 1993 Dec;61(6):2262-8
– reference: 20361984 - Life Sci. 2010 May 22;86(21-22):814-8
– reference: 11057521 - Psychopharmacology (Berl). 2000 Oct;152(2):174-80
– reference: 18268500 - Mol Psychiatry. 2009 Jun;14(6):601-13
– reference: 21669024 - Int J Neuropsychopharmacol. 2012 Jun;15(5):573-88
– reference: 8799184 - Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9235-40
– reference: 16005189 - Schizophr Res. 2005 Oct 1;78(1):69-86
– reference: 10211134 - Br J Psychiatry Suppl. 1999;(37):12-5
– reference: 9542890 - Cereb Cortex. 1998 Mar;8(2):108-16
– reference: 20493668 - Eur Neuropsychopharmacol. 2010 Oct;20(10):721-30
– reference: 22474070 - Arch Gen Psychiatry. 2012 Aug;69(8):776-86
– reference: 19700006 - Lancet. 2009 Aug 22;374(9690):635-45
– reference: 15118803 - Psychopharmacology (Berl). 2004 Jun;174(1):3-16
– reference: 9024661 - Nature. 1997 Feb 13;385(6617):634-6
– reference: 9545644 - Genomics. 1998 Mar 15;48(3):373-6
– reference: 14684259 - Behav Brain Res. 2004 Jan 5;148(1-2):185-98
– reference: 19011234 - Schizophr Bull. 2009 Mar;35(2):383-402
– reference: 11986129 - Am J Psychiatry. 2002 May;159(5):761-7
– reference: 17270739 - Neuron. 2007 Feb 1;53(3):439-52
– reference: 22213785 - Arch Gen Psychiatry. 2012 Jan;69(1):16-26
– reference: 17015235 - Neuron. 2006 Oct 5;52(1):179-96
– reference: 12154365 - Nat Rev Neurosci. 2002 Aug;3(8):641-53
– reference: 8628395 - Nature. 1996 Feb 15;379(6566):606-12
– reference: 16797265 - Biol Psychiatry. 2006 Jun 15;59(12):1198-207
– reference: 11077070 - Neuropharmacology. 2001;40(1):48-56
– reference: 16330585 - Am J Psychiatry. 2005 Dec;162(12):2233-45
– reference: 11549226 - Psychopharmacology (Berl). 2001 Jul;156(2-3):234-58
– reference: 17349856 - Int Rev Neurobiol. 2007;78:1-39
– reference: 19748077 - Biol Psychiatry. 2010 Feb 1;67(3):208-16
– reference: 11595398 - Schizophr Res. 2001 Oct 1;52(1-2):115-20
– reference: 20877280 - Nat Neurosci. 2010 Oct;13(10):1161-9
– reference: 16226876 - Schizophr Res. 2006 Jan 1;81(1):47-63
– reference: 11978847 - J Neurosci. 2002 May 1;22(9):3708-19
– reference: 16848689 - Expert Opin Ther Targets. 2006 Aug;10(4):515-31
– reference: 18690110 - Behav Pharmacol. 2008 Sep;19(5-6):562-5
– reference: 10951692 - Transgenic Res. 2000 Apr;9(2):81-9
– reference: 8785064 - Neuron. 1996 Mar;16(3):675-86
– reference: 18985177 - Acta Biochim Pol. 2008;55(4):619-28
SSID ssj0000548171
Score 2.0746443
Snippet Overexpression of the mammalian homolog of the unc-18 gene (munc18-1) has been described in the brain of subjects with schizophrenia. Munc18-1 protein is...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e221
SubjectTerms 631/1647/767/1424
692/420
692/699/476/1799
Animals
Behavior, Animal - physiology
Behavioral Sciences
Biological Psychology
Brain - metabolism
Caspase 3 - metabolism
Disease Models, Animal
Dopamine - metabolism
Humans
Lipid Peroxidation - genetics
Medicine
Medicine & Public Health
Mice
Mice, Inbred C57BL
Mice, Transgenic
Microdialysis
Motor Activity - genetics
Munc18 Proteins - genetics
Munc18 Proteins - metabolism
Nerve Fibers, Unmyelinated - pathology
Neurosciences
Organ Size - genetics
Original
original-article
Pharmacotherapy
Phenotype
Psychiatry
Recognition (Psychology) - physiology
Reflex, Startle - genetics
Schizophrenia - metabolism
SNARE Proteins - metabolism
Social Behavior
SummonAdditionalLinks – databaseName: SpringerOpen Free (Free internet resource, activated by CARLI)
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEB7aFEovIX3GTVoUSC6lptbDtpxbuiSEQHpKIDczsmRaaOyQdaD9Df3THcmy2e32kKs1toVGmodm5huAQw_4qCzaVLfkrqpCVCk6xVMSkpY3GW-t8bXDl9-K82t1cZPfRJztZUyrHCEtg5iessO-DB5bkgs62NVTeOYx2_12XhSL-UKFbA_NSx5r8DKpV99Z1zobpuRmRuQ_YdGgbc52YDuaiexknNhLeOK6V_D8MgbCX8Ofr3N5_WcWMCmbWPnPsLPstqflm8QaG4t7l4zcb2KkZeY3I7OP-eRN9ysmwnasb9ktKTlO7h4SKTO-eUR4SrLkmPnmKiFdgA09W66m6r2Bq7PTq8V5GvsqpA2p9yGVRjUCNc9RlsaWrcyQY-7y0mKWocGmaUh-2oo0l0ElnMk0lk4LVzmXFSjfwlbXd24XmOHa2DbHVlurLDlPKHhhW2Gc1IossQQ-TcteNxFz3Le--FmH2LfU9XBXex6RB1IlcDgT341QG_8n25_4V8fztqw9yKpHCtQigYN5mE6KD39g5_oHovFVSL6WVifwbmT3_B8hJVmumUqgXNsIM4FH4V4f6X58D2jckgziUtA3j6YtszKtzem_fyTdHrwQofOGv-3Zh63h_sF9IPtnMB_Dvv8L_QwH-Q
  priority: 102
  providerName: Springer Nature
Title Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia
URI https://link.springer.com/article/10.1038/tp.2012.149
https://www.ncbi.nlm.nih.gov/pubmed/23340504
https://www.proquest.com/docview/1791389982
https://www.proquest.com/docview/1273806548
https://pubmed.ncbi.nlm.nih.gov/PMC3566728
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF-0BfFF_DZajxXqixia_Uh244tcj5Zy0CJa4d7CbnZDBZtceyno3-A_7czeJvY88SmQDMmys5nv-Q0h-wj4KJ1xqW7AXZUFL1PjJUtBSDpWZ6xxFnuHT8-Kk69yvsgXMeC2imWVg0wMgtp1NcbIDxBGE7HgNP-4vEpxahRmV-MIjbtkF6HLsKRLLdQYYwFzRDPFYlteJvRBjxCVjIN8KDcV0ZZ1uV0k-VemNCig44fkQbQc6XTN6kfkjm8fk3unMTf-hPw6HDvu39MAU1lHMABqWkcvO9jRQdLRdb_vioJHDrx11P6kYAlSrOf0P2JtbEu7hl6C3mPgARogpRbnSYS7IF4-UJy3EioIaN_R1e3qvafk_PjofHaSxlELaQ0av0-FlTU3muVGKOtUIzLDTO5z5UyWGWvqugaR6kpQZtZI7m2mjfKa-9L7rDDiGdlpu9a_INQybV2Tm0Y7Jx34U4azwjXceqElGGcJeTdse1VHGHKchvG9Culwoat-WSGPwCkpE7I_Ei_X6Bv_Jtsb-FfFX3BV_TkwCXkzPoafBzMipvXdDdBgYxK21-qEPF-ze_wOFwKM2UwmRG0chJEAgbk3n7TfLgJAtwAbWXF459vhyNxa1vbyX_5_-a_IfR5mcGDcZ4_s9Nc3_jVYQr2dhOM-IbvT6fzLHK6HR2efPsPdWTGbhOjCb40rEd8
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9RAEB_qFdQX8dto1RXaFzE0-3GXjSBiteVqe4fICX0Lu9kNFtrk6qVo_wb_Fv9HZ_JlzxPf-poMmyUzOx87M78B2CTAR-WMC3WO4aoaiSQ0XvEQlaTjWcRzZ6l3eDIdjb-oj0fDozX41fXCUFllpxNrRe3KjO7ItwlGk7DgtHg7PwtpahRlV7sRGo1YHPiL7xiyLd7sf0D-bgmxtzt7Pw7bqQJhhsatCqVVmTCaD42MrYtzGRluhn4YOxNFxposy1B7uAT1tjVKeBtpE3stfOJ9NDISl70G60piJDOA9Z3d6afP_aUO-j-ax7ztA4yk3q4IE5MLVEjJsuVbcWdXqzL_Ss3WFm_vNtxqXVX2rpGtO7Dmi7twfdIm4-_Bz52-xf8Vq3ExsxZ9gJnCsdMSWdipVtY0GC_YceFQmByzFwxdT0YFpP5HW4xbsDJnp2hoOYacBkmZpQEW9VPUZ68ZDXipSxZYVbLF5XLB-zC7Ci48gEFRFv4RMMu1dfnQ5No55TCAM4KPXC6sl1qhNxjAy-63p1mLe07jN07SOv8udVrNU-IRRkFJAJs98byB-_g32UbHv7Q984v0j4QG8KJ_jaeVUjCm8OU50lAnFPXz6gAeNuzuvyOkRO85UgHES4LQExAS-PKb4vhrjQgu0SmPBa651YnMpW2tbv_x_7f_HG6MZ5PD9HB_evAEbop6AAhdOm3AoPp27p-iG1bZZ63wM0iv-Lj9BuHrTBI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcKt6kFDBSe0FEG9vJ2kFCCCirltKKQ5H2FtmxIyq1yZZNRfsb-ov4d8zkRZdF3HpNRo6VeXjGM_MNwBYBPsbOuFAXGK7GY5GGxsc8RCPpeB7xwlnqHT44HO9-iz9Pk-kK_Op7YaissreJjaF2VU535COC0SQsOC1GRVcW8XVn8m52FtIEKcq09uM0WhHZ95c_MXybv93bQV5vCzH5dPRxN-wmDIQ5HnR1KG2cC6N5YqSyThUyMtwkPlHORJGxJs9ztCQuRRtuTSy8jbRRXgufeh-NjcRlb8FtJRNOKqamarjeQU9Ic8W7jsBI6lFN6JhcoGlKF8_AJcd2uT7zryRtc_ZN7sJ657Sy962U3YMVX96HtYMuLf8Arj4Mzf6vWYOQmXc4BMyUjp1WyMzeyLK21XjOjkuHYuWYvWTohDIqJfUXXVluyaqCneKRyzH4NEjKLI2yaJ6iZXvDaNRLU7zA6orNrxcOPoSjm-DBI1gtq9I_AWa5tq5ITKGdix2GckbwsSuE9VLH6BcG8Kr_7VneIaDTII6TrMnES53Vs4x4hPFQGsDWQDxrgT_-TbbZ8y_rtH-e_ZHVAF4Or1FvKRljSl-dIw31RFFnrw7gccvu4TtCSvSjozgAtSAIAwFhgi--KY-_N9jgEt1zJXDN7V5krm1refsb_9_-C1hDJcu-7B3uP4U7opkEQrdPm7Ba_zj3z9Afq-3zRvIZZDesab8BVENO4g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Behavioral%2C+neurochemical+and+morphological+changes+induced+by+the+overexpression+of+munc18-1a+in+brain+of+mice%3A+relevance+to+schizophrenia&rft.jtitle=Translational+psychiatry&rft.au=Urig%C3%BCen%2C+L&rft.au=Gil-Pisa%2C+I&rft.au=Munarriz-Cuezva%2C+E&rft.au=Berrocoso%2C+E&rft.date=2013-01-01&rft.eissn=2158-3188&rft.volume=3&rft.spage=e221&rft_id=info:doi/10.1038%2Ftp.2012.149&rft_id=info%3Apmid%2F23340504&rft.externalDocID=23340504
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2158-3188&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2158-3188&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2158-3188&client=summon